Who Paid My Doc
Henri Roca
Integrative Medicine Saint Louis, MO Medical Doctor
NPI 1578584595 CMS profile 891792
9160 Clayton Rd, Saint Louis, MO 63124
General payments
$134
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Henri Roca of Saint Louis, MO is reported in the CMS Open Payments database as having received $134 across 2 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
By program year
2 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $24 | 1 | |
| 2022 | General | $111 | 1 |
Beside peers
- Henri Roca
- Integrative Medicine median
- Middle half of Integrative Medicine
- National median
In program year 2025, general payments to Henri Roca were reported at $24. Among 30 Integrative Medicine profiles paid that year, the median was $106 and the middle half received between $22 and $416.
Show as a table
| Year | Henri Roca | Integrative Medicine median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | — | — | $163 |
| 2020 | $0 | — | — | $114 |
| 2021 | $0 | — | — | $132 |
| 2022 | $111 | — | — | $149 |
| 2023 | $0 | — | — | $160 |
| 2024 | $0 | $214 | $33–$477 | $164 |
| 2025 | $24 | $106 | $22–$416 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 8 drugsPart D claims
120
Drug cost
$2,635
Branded share of claims
9.2%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Estradiol | Generic | 15 | $1,298 | |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | Brand | 11 | $668 | |
| Rosuvastatin Calcium | Generic | 24 | $309 | |
| Amlodipine Besylate | Generic | 17 | $120 | |
| Escitalopram Oxalate | Generic | 12 | $73 | |
| Alprazolam | Generic | 17 | $70 | |
| Losartan Potassium | Generic | 11 | $56 | |
| Prednisone | Generic | 13 | $40 |
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero.
Records
2 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Related records
Integrative Medicine in Missouri
Practitioners in the same specialty and state, ranked by reported value.
All Integrative Medicine
Everyone recorded under this specialty, nationwide.
Doctors in Missouri
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.